Utility of Recombinant Envelope Domain III as a Diagnostic Antigen for the Specific Detection of Kyasanur Forest Disease
Related Experiment Video
Updated: Jan 25, 2026

Immunization of Alpacas Lama pacos with Protein Antigens and Production of Antigen-specific Single Domain Antibodies
Published on: January 26, 2019
Sayad Hafeez1, Rajeshwara Achur2, Vivek Vijay3
1Department of PG Studies and Research in Microbiology, Kuvempu University, Jnana Sahyadri, Shankaraghatta, Karnataka, India.
Abstract:
Kyasanur Forest Disease (KFD), commonly known as 'monkey fever,' is a highly neglected tropical disease caused by the Kyasanur Forest Disease Virus (KFDV). KFD is endemic to the Western Ghats of Karnataka, India, with seasonal outbreaks during December to June every year. As there is no standard treatment regime, KFD can be fatal with a mortality rate of 2%-10%. Currently, KFD is detected through a non-specific IgM-ELISA followed by RT-PCR, which often delays diagnosis, leading to increased disease severity and even death. To address this, we focused on developing a specific antigen-based KFD detection. The KFDV Envelope Domain III (EDIII) and Non-Structural 1 (NS1) proteins were chosen as detection markers, cloned, and expressed using pET28a(+) vector in BL-21 (Rosetta) E. coli and purified. These proteins were used to raise polyclonal antibodies in rabbits and the antibody titre was found to be 1:256 000 and 1:512 000 against rEDIII and rNS1 proteins, respectively. Importantly, these polyclonal antibodies showed no cross-reactivity against corresponding dengue virus EDIII and NS1 proteins. Using polyclonal antibodies against rEDIII, we developed sandwich ELISA for the specific detection of KFD, which has demonstrated high specificity and sensitivity. Further, anti-rEDIII polyclonal antibodies also detected full-length KFDV-E protein expressed in mammalian cells, confirming the antibody specificity for the native viral antigen.
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Acute Coronary Syndrome III: Diagnostic Studies
Hypertension III: Clinical Manifestations and Diagnostic Studies
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...

